Immunohistochemical characterization of γ-secretase activating protein expression in Alzheimer's disease brains

被引:27
作者
Satoh, J. [1 ]
Tabunoki, H. [1 ]
Ishida, T. [2 ]
Saito, Y. [3 ]
Arima, K. [4 ]
机构
[1] Meiji Pharmaceut Univ, Dept Bioinformat & Mol Neuropathol, Tokyo 2048588, Japan
[2] Kohnodai Hosp, NCGM, Dept Pathol & Lab Med, Chiba, Japan
[3] Natl Ctr Hosp, NCNP, Dept Lab Med, Tokyo, Japan
[4] Natl Ctr Hosp, NCNP, Dept Psychiat, Tokyo, Japan
关键词
Alzheimer's disease; amyloid-ss; GSAP; immunohistochemistry; PION;
D O I
10.1111/j.1365-2990.2011.01206.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aims: A recent study showed that gamma-secretase activating protein (GSAP), derived from a C-terminal fragment of pigeon homolog (PION), increases amyloid-beta (A beta) production by interacting with presenilin-1 (PS1) and the beta-secretase-cleaved C-terminal fragment of amyloid precursor protein (APP-CTF). In the study, knockdown of GSAP reduces production of A beta and plaque formation in the brain of APPswe and PS1 Delta E9 double transgenic mice without affecting the Notch-dependent pathway. Therefore, GSAP is an ideal target for designing gamma-secretase modulators with least side effects in Alzheimer's disease (AD). However, at present, the precise distribution of GSAP in AD brains remains to be characterized. Methods: By immunohistochemistry, we studied GSAP expression in the frontal cortex and the hippocampus of 11 aged AD and 17 age-matched control cases. Results: GSAP immunoreactivity exhibited distinct morphological features, such as fine granular cytoplasmic deposits, dense nodular and patchy deposits, beads and string-like deposits, and diffuse dot-like deposits. In both AD and control brains, a fairly small subset of cerebral cortical and hippocampal neurones expressed fine granular cytoplasmic deposits, while diffuse dot-like deposits were more frequently found in the neuropil and neuronal processes, particularly enriched in the hippocampal CA2 and CA3 regions. Among GSAP-immunoreactive deposits, dense nodular and patchy deposits, located in the neuropil and closely associated with PS1 expression and A beta deposition, indicated the most distinguishing features of AD pathology. Conclusions: Aberrant regulation of GSAP expression plays a key role in acceleration of gamma-cleavage of APP-CTF and accumulation of A beta in AD brains.
引用
收藏
页码:132 / 141
页数:10
相关论文
共 12 条
[1]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[2]   Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry [J].
Braak, Heiko ;
Alafuzoff, Irina ;
Arzberger, Thomas ;
Kretzschmar, Hans ;
Del Tredici, Kelly .
ACTA NEUROPATHOLOGICA, 2006, 112 (04) :389-404
[3]   Novel Research Horizons for Presenilins and γ-Secretases in Cell Biology and Disease [J].
De Strooper, Bart ;
Annaert, Wim .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 26, 2010, 26 :235-260
[4]   Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease [J].
He, Gen ;
Luo, Wenjie ;
Li, Peng ;
Remmers, Christine ;
Netzer, William J. ;
Hendrick, Joseph ;
Bettayeb, Karima ;
Flajolet, Marc ;
Gorelick, Fred ;
Wennogle, Lawrence P. ;
Greengard, Paul .
NATURE, 2010, 467 (7311) :95-U129
[5]   THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .2. STANDARDIZATION OF THE NEUROPATHOLOGIC ASSESSMENT OF ALZHEIMERS-DISEASE [J].
MIRRA, SS ;
HEYMAN, A ;
MCKEEL, D ;
SUMI, SM ;
CRAIN, BJ ;
BROWNLEE, LM ;
VOGEL, FS ;
HUGHES, JP ;
VANBELLE, G ;
BERG, L .
NEUROLOGY, 1991, 41 (04) :479-486
[6]   Close association of water channel AQP1 with amyloid-β deposition in Alzheimer disease brains [J].
Misawa, Tamako ;
Arima, Kunimasa ;
Mizusawa, Hidehiro ;
Satoh, Jun-ichi .
ACTA NEUROPATHOLOGICA, 2008, 116 (03) :247-260
[7]   Gleevec inhibits β-amyloid production but not Notch cleavage [J].
Netzer, WJ ;
Dou, F ;
Cai, DM ;
Veach, D ;
Jean, S ;
Li, YM ;
Bornamann, WG ;
Clarkson, B ;
Xu, HX ;
Greengard, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (21) :12444-12449
[8]  
Satoh J, 2009, DIS MARKERS, V27, P239, DOI [10.1155/2009/618619, 10.3233/DMA-2009-0670]
[9]   Alzheimer's disease: Genes, proteins, and therapy [J].
Selkoe, DJ .
PHYSIOLOGICAL REVIEWS, 2001, 81 (02) :741-766
[10]   Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3 [J].
Shioya, M. ;
Obayashi, S. ;
Tabunoki, H. ;
Arima, K. ;
Saito, Y. ;
Ishida, T. ;
Satoh, J. .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2010, 36 (04) :320-330